Status:
COMPLETED
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
Lead Sponsor:
Duramed Research
Conditions:
Contraception
Eligibility:
FEMALE
18-40 years
Phase:
PHASE3
Brief Summary
This study is being conducted to evaluate the safety of ethinyl an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an addition...
Detailed Description
This study is being conducted to evaluate the safety of an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an additional three...
Eligibility Criteria
Inclusion
- Participant in the earlier Phase 3 Seasonique clinical trial
Exclusion
- Any contraindication to the use of oral contraceptives
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00196352
Start Date
May 1 2003
End Date
November 1 2006
Last Update
April 8 2014
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Duramed Investigational Site
Tucson, Arizona, United States, 85715
2
Duramed Investigational Site
Washington D.C., District of Columbia, United States, 20006
3
Duramed Investigational Site
Lincoln, Nebraska, United States, 68510
4
Duramed Investigational Site
Rochester, New York, United States, 14609